Country Profile

China

China is a major destination for Indian pharmaceutical exports — $286M in FY 2025–26, with 2.6× growth over the past decade. Medicine Ingredients accounts for 64% of shipments, with vaccines contributing $240K. The compound annual growth rate since FY2015 stands at 9.1%.

🇨🇳 #16 Destination · $286M · 2.6× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$286M
Exports FY2025–26 DGCIS
2.6×
Growth FY2015→2026
0.9%
Share of India Total
#16
Rank Among 178 Markets
9.1%
CAGR FY2015→2026
China is a major destination for Indian pharmaceutical exports — $286M in FY 2025–26, with 2.6× growth over the past decade. Medicine Ingredients accounts for 64% of shipments, with vaccines contributing $240K. The compound annual growth rate since FY2015 stands at 9.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $182M (63.6%) Medicines $80.7M (28.2%) Traditional & Herbal $16.2M (5.7%) Surgical & Hospital Supplies $7.03M (2.5%) Vaccines $240K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to China in the RBI overseas direct investment dataset (2011–2026).